Antiviral Research 47 (2000) 221 – 222
Author index
Volume 47 (2000)
Abu Sheikha, G., see Franchetti, P. 47, 149 Andreotti, M., see Vella, S. 47, 189 Angeretti, A., see Lembo, D. 47, 111 Ariga, T., see Matsuyama, S. 47, 131 Bailey, K.W., see Smee, D.F. 47, 171 Balestra, E., see Franchetti, P. 47, 149 Belec, L., see Karmochkine, M. 47, 179 Benatti, U., see Franchetti, P. 47, 149
Bernstein, D.I., J. Ireland, N. Bourne, Pathogenesis of acy-clovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evalua-tions 47, 159
Bernstein, D.I., see Bourne, N. 47, 103 Binelli, A., see Vella, S. 47, 189
Blanchard, S.G., see Lenhard, J.M. 47, 121
Bourne, N., F.J. Bravo, D.I. Bernstein, Cyclic HPMPC is safe and effective against systemic guinea pig cytomegalovirus infection in immune compromised animals 47, 103 Bourne, N., see Bernstein, D.I. 47, 159
Brandi, G., see Franchetti, P. 47, 149 Bravo, F.J., see Bourne, N. 47, 103 Bucciardini, R., see Vella, S. 47, 189 Bukrinsky, M., see Glushakova, S. 47, 89 Callahan, M., see Craigo, J. 47, 19 Cappellacci, L., see Franchetti, P. 47, 149 Cavallo, R., see Lembo, D. 47, 111 Cho, C.-W., see Cho, Y.-S. 47, 199
Cho, Y.-S., C.-W. Cho, O. Joung, K.-A. Lee, S.-N. Park, D.-Y. Yoon, Development of screening systems for drugs against human papillomavirus-associated cervical cancer: based on E6-E6AP binding 47, 199
Craigo, J., M. Callahan, R.C.C. Huang, A.L. DeLucia, Inhibi-tion of human papillomavirus type 16 gene expression by nordihydroguaiaretic acid plant lignan derivatives 47, 19 Crump, C.E., see Kaiser, L. 47, 217
DeLucia, A.L., see Craigo, J. 47, 19
Dubrovsky, L., see Glushakova, S. 47, 89 El Alaoui, A.M., see Faraj, A. 47, 97
Faraj, A., A.M. El Alaoui, G. Gosselin, J.-L. Imbach, C. Morrow, J.-P. Sommadossi, Effects of b-L-3%-azido-3% -de-oxythymidine 5%-triphosphate on host and viral DNA poly-merases 47, 97
Floridia, M., see Vella, S. 47, 189 Fragola, V., see Vella, S. 47, 189
Franchetti, P., G. Abu Sheikha, L. Cappellacci, S. Marchetti, M. Grifantini, E. Balestra, C.-F. Perno, U. Benatti, G. Brandi, L. Rossi, M. Magnani, A new acyclic heterodinucle-otide active against Human Immunodeficiency Virus and Herpes Simplex Virus 47, 149
Furfine, E.S., see Lenhard, J.M. 47, 121 Galluzzo, M.C., see Vella, S. 47, 189 Giannini, G., see Vella, S. 47, 189
Ginsburg, C., see Karmochkine, M. 47, 179
Glushakova, S., L. Dubrovsky, J.-C. Grivel, O. Haffar, M. Bukrinsky, Small molecule inhibitor of HIV-1 nuclear im-port suppresses HIV-1 replication in human lymphoid tissue ex vivo: a potential addition to current anti-HIV drug repertoire 47, 89
Gosselin, G., see Faraj, A. 47, 97 Gribaudo, G., see Lembo, D. 47, 111 Grifantini, M., see Franchetti, P. 47, 149 Grivel, J.-C., see Glushakova, S. 47, 89 Gutmann, L., see Karmochkine, M. 47, 179 Haffar, O., see Glushakova, S. 47, 89 Hayden, F.G., see Kaiser, L. 47, 217 Henmi, S., see Matsuyama, S. 47, 131 Huang, R.C.C., see Craigo, J. 47, 19 Ichihara, N., see Matsuyama, S. 47, 131 Imbach, J.-L., see Faraj, A. 47, 97 Ireland, J., see Bernstein, D.I. 47, 159
Author index
222
Isaacs, C.E., W. Xu, R.K. Pullarkat, R. Kascsak, Retinoic acid reduces the yield of herpes simplex virus in Vero cells and alters the N-glycosylation of viral envelope proteins 47, 29
Itoh, N., see Kanekiyo, M. 47, 207 Ittoop, O., see Lenhard, J.M. 47, 121 Jain, R.G., see Lenhard, J.M. 47, 121 Joung, O., see Cho, Y.-S. 47, 199
Kaiser, L., C.E. Crump, F.G. Hayden, In vitro activity of pleconaril and AG7088 against selected serotypes and clini-cal isolates of human rhinoviruses 47, 217
Kanekiyo, M., N. Itoh, M. Mano, A. Kawasaki, J. Tanaka, N. Muto, K. Tanaka, Cellular zinc status regulates cy-tomegalovirus major immediate-early promoter 47, 207 Karmochkine, M., A. Si Mohamed, C. Piketty, C. Ginsburg,
G. Raguin, V. Schneider-Fauveau, L. Gutmann, M.D. Kazatchkine, L. Belec, The cumulative occurrence of resis-tance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients 47, 179 Kascsak, R., see Isaacs, C.E. 47, 29
Kawasaki, A., see Kanekiyo, M. 47, 207 Kazatchkine, M.D., see Karmochkine, M. 47, 179 Kikuchi, T., see Matsuyama, S. 47, 131
Kimura, K., S. Mori, K. Tomita, K. Ohno, K. Takahashi, S. Shigeta, M. Terada, Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo 47, 41
Landolfo, S., see Lembo, D. 47, 111 Lee, K.-A., see Cho, Y.-S. 47, 199
Lembo, D., G. Gribaudo, L. Riera, A. Mondo, R. Cavallo, A. Angeretti, S. Landolfo, The thymidylate synthase inhibitor ZD1694 potently inhibits murine and human cy-tomegalovirus replication in quiescent fibroblasts 47, 111 Lenhard, J.M., E.S. Furfine, R.G. Jain, O. Ittoop, L.A.
Or-band-Miller, S.G. Blanchard, M.A. Paulik, J.E. Weiel, HIV protease inhibitors block adipogenesis and increase lipolysis in vitro 47, 121
Magnani, M., see Franchetti, P. 47, 149 Mano, M., see Kanekiyo, M. 47, 207 Marchand, C., see Pommier, Y. 47, 139 Marchetti, S., see Franchetti, P. 47, 149
Matsuyama, S., S. Henmi, N. Ichihara, S. Sone, T. Kikuchi, T. Ariga, F. Taguchi, Protective effects of murine recombi-nant interferon-badministered by intravenous, intramuscu-lar or subcutaneous route on mouse hepatitis virus infection 47, 131
McKimm-Breschkin, J.L., Resistance of influenza viruses to neuraminidase inhibitors — a review 47, 1
Mentel, R., U. Wegner, Evaluation of the efficacy of 2%,3% -dideoxycytidine against adenovirus infection in a mouse pneumonia model 47, 79
Mondo, A., see Lembo, D. 47, 111
Mori, S., see Kimura, K. 47, 41 Morrow, C., see Faraj, A. 47, 97 Muto, N., see Kanekiyo, M. 47, 207 Neamati, N., see Pommier, Y. 47, 139 Ohno, K., see Kimura, K. 47, 41
Orband-Miller, L.A., see Lenhard, J.M. 47, 121 Park, S.-N., see Cho, Y.-S. 47, 199
Paulik, M.A., see Lenhard, J.M. 47, 121 Perno, C.-F., see Franchetti, P. 47, 149 Piketty, C., see Karmochkine, M. 47, 179 Pirillo, M.F., see Vella, S. 47, 189
Pommier, Y., C. Marchand, N. Neamati, Retroviral integrase inhibitors year 2000: update and perspectives 47, 139 Pullarkat, R.K., see Isaacs, C.E. 47, 29
Raguin, G., see Karmochkine, M. 47, 179 Ricciardulli, D., see Vella, S. 47, 189 Riera, L., see Lembo, D. 47, 111 Rossi, L., see Franchetti, P. 47, 149
Sawyer, L.A., Antibodies for the prevention and treatment of viral diseases 47, 57
Schneider-Fauveau, V., see Karmochkine, M. 47, 179 Shigeta, S., see Kimura, K. 47, 41
Sidwell, R.W., see Smee, D.F. 47, 171 Si Mohamed, A., see Karmochkine, M. 47, 179
Smee, D.F., K.W. Bailey, M.-H. Wong, R.W. Sidwell, In-tranasal treatment of cowpox virus respiratory infections in mice with cidofovir 47, 171
Sommadossi, J.-P., see Faraj, A. 47, 97 Sone, S., see Matsuyama, S. 47, 131 Taguchi, F., see Matsuyama, S. 47, 131 Takahashi, K., see Kimura, K. 47, 41 Tanaka, J., see Kanekiyo, M. 47, 207 Tanaka, K., see Kanekiyo, M. 47, 207 Terada, M., see Kimura, K. 47, 41 Tomino, C., see Vella, S. 47, 189 Tomita, K., see Kimura, K. 47, 41
Vella, S., M.C. Galluzzo, G. Giannini, M.F. Pirillo, M. An-dreotti, C. Tomino, V. Fragola, R. Bucciardini, D. Ricciar-dulli, A. Binelli, L.E. Weimer, M. Floridia, Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment 47, 189 Wegner, U., see Mentel, R. 47, 79
Weiel, J.E., see Lenhard, J.M. 47, 121 Weimer, L.E., see Vella, S. 47, 189 Wong, M.-H., see Smee, D.F. 47, 171 Xu, W., see Isaacs, C.E. 47, 29 Yoon, D.-Y., see Cho, Y.-S. 47, 199 .
